The effect of hGH treatment was studied in 21 prepubertal (12 M, 9 F) GH deficient children (14 IGHD, 7 MPHD) treated for 5 yrs. They were grouped according to age at start of therapy: Gr. A: CA 0.9-4.8, BA 121 y; Gr. B: CA 5.1-9.9, BA 3.822 y. The initial dose of hGH was 2-4 IUx31wk. In Gr. A the mcan height SDS gain in the flrst year was 1.5 compared to 0.8 in Gr. B. In the 2nd year height SDS gain was 0.8 and 0.2 respectively. The SDS gains decreased with years of therapy. The bone age advancement was faster in Gr. B. It is concluded that initiation of hCH therapy in early age is most effective for height normalization, especially in isolated hGH deficiency.
hGH RESPONSE TO GH-RH Fourteen juveniles with obesity were tested with i.v. GH-RH 1-44 (1 mcglkg). Seven had simple obesity and in the other 7 the obesity was associated with the following syndromes: Prader-Willi (n=4); Laurence Moon Biedle (n=l); hypothalamic syndrome (n-2). The overweight (Owt) SDS was calculated by substracting height SDS from weight SDS. The subjects were grouped according to the diagnosis and Owt SDS (Table) . In simple obesity (Gr. 1+2) there was a good response of hGR to GH-RH (11.825.8 ngiml) whereas in the syndromes (Gr. 3+4) there was a poor response (3.222.1 ng/ml p <0.01). In groups 2 & 3 there was a similar Owt SDS, but different etiologies of the obesity with a sign~ficantly reduced hCH response in the syndromes (Gr. 3; p <0.01). Though the blunted response of hGH to pharmacologic stimuli as well as to sleep and GH-RII in obesity is rclatcd to the degree of Owt, it is concluded that additional factors contribute to the pattern of hCll secretion and rcsponse in obesity.
Age A 27 European centers collaborative study (supported by SANOFI.) was undertaken to assess the effect of a 2~g/kg/body weight I.V. bolus of synthetic 1-44 GRF(SANOF1.) on plasma immunoreactive GH in children w-th growth failure. I06 among the first I06 tested (further analysis extended to 500), in strict compliance with the protocole according to an independent Validation Committee (V.G.) were accepted and classified as: A= no GH deficiency(n=43),B=par-tial GH deficiency(n=23),C=total GH deficiency(n=34) according to a GH peak(mUI/ml) above 20(A) ,between 19.9 and IO.I(B) or below IO(C) assessed by I or 2 conventional GH secretion provocative tests prior to GRF. The likely cause of growth failure was CNS disorder (n=22), Idiopathic GH deficiency (IGHD, n=38), Chronic disease (n=6), Constitutional short stature (n=40). :lean GH peak (mUI/ml) after GRF were 48.8(A), 32.6(B) and 16.4(C) at 45', 30' and 60' respectively. In partial(B) or total (C) IGHD, mean GH peak (mUI/ml) were 35.8 and 14.3. A ~o o d relationship between the GH response to grf and the bio-clinical diagnostic classifisation established by the V.C. was observed. 12/34 patients of C displayed an improved GH response after GRF, previosuly underestimated by other secretagogues. GRF proves to be a well tolerated,usefull and non invasive mean in the assessment of GF secretion in growth deficient children. Prl, specially among B.hyperprolactinemics (r=0.62-p 0.005). Surprisingly no correlation was found in any group between B.Prl and GH nor Prl and GH. Some subjects displayed a Prl peak with no GH peak, others a GH peak and no Prl peak. This study confirms that GRF can induce a Prl rise. Gascular flush is not the only possible explanation. A Prl peak with no GH response suggests that GRF had reached the pituitary and non functionnal or atrophic Somatotrophs. Chronic GRF stimulation may be required to maintain or induce functionnal Somatotrophs. In GH deficiency. B.hyper-Prl cannot predict GH response to GRF. Asinle GRF injection cannot exclude GRF deficit.l'r1 is worthwile assaying after GRP .
EFFECT OF ACUTE I.V. GROWTH HORMONE-RELEASING-FACTOR (GRF) ON PLASMA PROLACTIN(Pr1) IN GROWTH HORYONE(GH

SHORT STATURE AND CELIAC DISEASE: CAN THE SIWPLE DETECTION OF THE
ANTIBODIES TO GLIADIH RESOLVE THIS RELATIONSHIP?
E . C a c c i a r i . S . S a l a r d i , S . P a r t e s o t t i , U.Valta. A.Cicognani. R.Lazz a r i , G.Biasco. G.R.Corazza. m i n a f t e r i n j e c t i o n . A s i g n i f i c a n t GH-response (L 4ng/ml) was a t t a i n e d i n 13 p a t i e n t s ( 1 1 u i t h i s o l a t e d G H -d e f i c i e n c y and 2 u i t h m u l t i p l e hormone d e f i c i e nc i e s ) ; GH l e v e l s i n c r e a s e d a t 15 min and r e a c h e d a peak a t 30 min. I n t h e s e p a t i e n t s a s i g n i f i c a n t i n c r e a s e i n HPRL l e v e l s was o b s e r v e d a f t e r 15-30 min. I n t h e whole group t h e r e u e r e no changes i n ACTH, TSH and SmC l e v e l s . The 7 p a t i e n t s uho d i d n o t r e s p o n d t o GH-RF were n o t d i f f e r e n t u i t h r e g a r d s t o age.
S.Orsola H o s p i t a l . U n i v e r s i t y OF Bologna, I t a l y 107 n o n s e l e c t e d c h i l d r e n ( 7 7 m. and 30 F.) u i t h s h o r t s t a t u r e and absence OF g a s t r o i n t e s t i n a l t r a c t symptoms uere examined. I n a d d i t i o n t o t h e n o r m a l t e s t s f o r t h e p a t h o g e n e t i c d e f i n i t i o n OF s h o r t s t a t u r e , i n a l l p a t i e n t s a d u o d e n a l b i o p s y was p e r f o r m e d and a n t i b o d i e s t o g l i a d i n were d e t e c t e d ( i m m u n o f l u a r e s c e n c e (IFL-AGA) and a micro-ELISA method (ELISA-AGA)) Ye Found 8 c h i l d r e n (7.5%) u i t h t o t a l v i l l o u s a t r o p h y p r o b a b l y due t o c e l i a c d i s e a s e . 7 c h i l d r e n (6.5%) u i t h p a r t i a l v i l l o u s a t r o p h y . and 4 c h i l d r e n (3.7%) w i t h c o m p l e t e GH d e f i c i e n c y .
IFL-AGA u e r e f o u n d i n 1 7 (15.9%) cases: i n a l l t h e 8 (100%) c h i l d r e n w i t h t o t a l v i l l o u s a t r o p h y , i n 3 (42.8%) c h i l d r e n w i t h p a r t i a l v i l l o u s a t r o p h y . and i n 6 (6.5%) s h o r t n o r m a l c h i l d r e n . ELISA-AGA v e r e d e t e c t e d i n : 7 (87.5%) o f t h e 8 c h i l d r e n u i t h t o t a l v i l l o u s a t r o p h y , i n 4 (57.1%) p a t i e n t s u i t h p a r t i a l v i l l o u s a t r o p h y , i n 1 (25%) p a t i e n t w i t h c o m p l e t e GH
sex, d u r a t i o n of t r e a t m e n t and r e s p o n s e t o t h e l a t t e r , From t h o s e who d i d
respond. I n o u r s t u d y a h y p o t h a l a m i c d e f i c i e n c y uas p r e s e n t i n 65% o f t h e s u b j e c t s . These d a t a s u g g e s t t h a t GH-RF c o u l d b e u s e f u l i n t h e t r e a t m e n t o f a h i g h p e r c e n t a g e o f G H -d e f i c i e n t p a t i e n t s .
